131 related articles for article (PubMed ID: 11166835)
1. Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome.
Tefferi A; Elliott MA; Steensma DP; Hook CC; Dispenzieria A; Hanson CA; Schroeder G; Letendre L
Leuk Res; 2001 Feb; 25(2):183-5. PubMed ID: 11166835
[TBL] [Abstract][Full Text] [Related]
2. Amifostine plus erythropoietin in a patient with low-risk myelodysplastic syndrome.
Musch E; Malek M; Chrissafidou A
Ann Hematol; 2003 Apr; 82(4):244-6. PubMed ID: 12707729
[TBL] [Abstract][Full Text] [Related]
3. [Short-term curative effect of amifostine combined with rhEPO on aged patients wilh myelodysplastic syndrome].
Lu XC; Zhu HL; Yao SQ; Fan H; Zhuang XM; Yang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):440-2. PubMed ID: 15972137
[TBL] [Abstract][Full Text] [Related]
4. [Amifostine used in the treatment of patients with myelodysplastic syndrome].
Li SX; Zhu HL; Lu XC; Fan H; Yao SQ; Ma J; Yang QM; Cai LL; Zhuang XM; Yang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):86-90. PubMed ID: 17490528
[TBL] [Abstract][Full Text] [Related]
5. [Application of bioinformatics analysis to optimize amifostine combination therapeutic regimen of myelodysplastic syndrome].
Lu XC; Yang B; Zhu HL; Fan H; Li SX; Liu Y; Yao SQ
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1834-7. PubMed ID: 19953928
[TBL] [Abstract][Full Text] [Related]
6. Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
Neumeister P; Jaeger G; Eibl M; Sormann S; Zinke W; Linkesch W
Leuk Lymphoma; 2001 Jan; 40(3-4):345-9. PubMed ID: 11426556
[TBL] [Abstract][Full Text] [Related]
7. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromes.
Grossi A; Musto P; Santini V; Balestri F; Fabbri A; Falcone A; Sanpaolo G
Haematologica; 2002 Mar; 87(3):322-3. PubMed ID: 11869946
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with myelodysplastic syndrome with amifostine.
Galanopoulos A; Kritikou-Griva E; Gligori J; Michalis E; Grigoraki V; Marinakis T; Kakkas J; Tasiopoulou A; Anagnostopoulos NI
Leuk Res; 2001 Aug; 25(8):665-71. PubMed ID: 11397471
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases.
Itzykson R; Ayari S; Vassilief D; Berger E; Slama B; Vey N; Suarez F; Beyne-Rauzy O; Guerci A; Cheze S; Thomas X; Stamatoullas A; Gardembas M; Bauduer F; Kolb A; Chaury MC; Legros L; Damaj G; Chermat F; Dreyfus F; Fenaux P; Ades L;
Leukemia; 2009 Apr; 23(4):673-8. PubMed ID: 19151787
[TBL] [Abstract][Full Text] [Related]
11. [Short-term curative effect of amifostine combined with rhbeta-EPO on patients with pure erythroid aplasia].
Li SX; Zhu HL; Lu XC; Fan H; Guo B; Zhai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1103-6. PubMed ID: 18928605
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.
Musto P; Falcone A; Sanpaolo G; Bodenizza C; La Sala A; Perla G; Carella AM
Br J Haematol; 2003 Jul; 122(2):269-71. PubMed ID: 12846896
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.
List AF; Brasfield F; Heaton R; Glinsmann-Gibson B; Crook L; Taetle R; Capizzi R
Blood; 1997 Nov; 90(9):3364-9. PubMed ID: 9345018
[TBL] [Abstract][Full Text] [Related]
14. Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
Erikci AA; Ozturk A; Karagoz B; Bilgi O; Turken O; Top C; Kandemir EG
Hematology; 2008 Oct; 13(5):289-92. PubMed ID: 18854092
[TBL] [Abstract][Full Text] [Related]
15. Sustained response to recombinant human erythropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes.
Stasi R; Brunetti M; Terzoli E; Amadori S
Blood; 2002 Mar; 99(5):1578-84. PubMed ID: 11861271
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological effects of erythropoietin treatment of myelodysplastic syndrome.
Razzano M; Caslini C; Cortelazzo S; Battistel V; Rambaldi A; Barbui T
Leuk Lymphoma; 1993 May; 10(1-2):127-34. PubMed ID: 8374520
[TBL] [Abstract][Full Text] [Related]
17. Amifostine in the treatment of low-risk myelodysplastic syndromes.
Grossi A; Fabbri A; Santini V; Leoni F; Nozzoli C; Longo G; Pagliai G; Ciolli S; Rossi Ferrini P
Haematologica; 2000 Apr; 85(4):367-71. PubMed ID: 10756361
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes.
Tsiara SN; Kapsali HD; Panteli K; Christou L; Bourantas KL
J Exp Clin Cancer Res; 2001 Mar; 20(1):35-8. PubMed ID: 11370827
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Viniou N; Terpos E; Galanopoulos A; Kritikou-Griva E; Akel S; Michalis E; Apostolidou E; Georgiadou D; Kouraklis A; Parharidou A; Kokkini G; Symeonidis A; Anagnostopoulos NI; Christakis JI; Tasiopoulou A; Loukopoulos D; Yataganas X
Ann Hematol; 2002 Apr; 81(4):182-6. PubMed ID: 11976818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]